124 related articles for article (PubMed ID: 37921725)
1. Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).
Marcoux P; Imeri J; Desterke C; Latsis T; Chaker D; Hugues P; Griscelli AB; Turhan AG
Cytotherapy; 2024 Jan; 26(1):63-72. PubMed ID: 37921725
[TBL] [Abstract][Full Text] [Related]
2. Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs).
Marcoux P; Hwang JW; Desterke C; Imeri J; Bennaceur-Griscelli A; Turhan AG
Cells; 2023 Dec; 12(24):. PubMed ID: 38132167
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional landscape of a RET
Hadoux J; Desterke C; Féraud O; Guibert M; De Rose RF; Opolon P; Divers D; Gobbo E; Griscelli F; Schlumberger M; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2018 Jan; 26():8-16. PubMed ID: 29197744
[TBL] [Abstract][Full Text] [Related]
4. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
5. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L
Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986
[TBL] [Abstract][Full Text] [Related]
7. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
8. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
9. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
10. NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells.
Brault J; Vigne B; Meunier M; Beaumel S; Mollin M; Park S; Stasia MJ
Free Radic Biol Med; 2020 Jan; 146():107-118. PubMed ID: 31626946
[TBL] [Abstract][Full Text] [Related]
11. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells.
Xu Y; Liu L; Zhang L; Fu S; Hu Y; Wang Y; Fu H; Wu K; Xiao H; Liu S; Yu X; Zheng W; Feng B; Huang H
PLoS One; 2012; 7(4):e34321. PubMed ID: 22496789
[TBL] [Abstract][Full Text] [Related]
12. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
13. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
[TBL] [Abstract][Full Text] [Related]
14. Monoallelic KRAS (G13C) mutation triggers dysregulated expansion in induced pluripotent stem cell-derived hematopoietic progenitor cells.
Lin HT; Takagi M; Kubara K; Yamazaki K; Michikawa F; Okumura T; Naruto T; Morio T; Miyazaki K; Taniguchi H; Otsu M
Stem Cell Res Ther; 2024 Apr; 15(1):106. PubMed ID: 38627844
[TBL] [Abstract][Full Text] [Related]
15. The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function.
Fonseca-Pereira D; Arroz-Madeira S; Rodrigues-Campos M; Barbosa IA; Domingues RG; Bento T; Almeida AR; Ribeiro H; Potocnik AJ; Enomoto H; Veiga-Fernandes H
Nature; 2014 Oct; 514(7520):98-101. PubMed ID: 25079320
[TBL] [Abstract][Full Text] [Related]
16. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.
Espinoza JL; Elbadry MI; Chonabayashi K; Yoshida Y; Katagiri T; Harada K; Nakagawa N; Zaimoku Y; Imi T; Takamatsu H; Ozawa T; Maruyama H; Hassanein HA; Khalifa A Noreldin A; Takenaka K; Akashi K; Hamana H; Kishi H; Akatsuka Y; Nakao S
Blood Adv; 2018 Feb; 2(4):390-400. PubMed ID: 29472446
[TBL] [Abstract][Full Text] [Related]
17. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.
Yang Z; Qi X; Gross N; Kou X; Bai Y; Feng Y; Wang B; Zafereo ME; Li G; Sun C; Li H; Chen X; Huang Z
J Cell Mol Med; 2020 Nov; 24(22):13163-13170. PubMed ID: 32989896
[TBL] [Abstract][Full Text] [Related]
18. Role of SOX17 in hematopoietic development from human embryonic stem cells.
Nakajima-Takagi Y; Osawa M; Oshima M; Takagi H; Miyagi S; Endoh M; Endo TA; Takayama N; Eto K; Toyoda T; Koseki H; Nakauchi H; Iwama A
Blood; 2013 Jan; 121(3):447-58. PubMed ID: 23169777
[TBL] [Abstract][Full Text] [Related]
19. Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia.
Shigemura T; Matsuda K; Kurata T; Sakashita K; Okuno Y; Muramatsu H; Yue F; Ebihara Y; Tsuji K; Sasaki K; Nakahata T; Nakazawa Y; Koike K
Br J Haematol; 2019 Oct; 187(2):163-173. PubMed ID: 31222725
[TBL] [Abstract][Full Text] [Related]
20. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
